Topical Treatment of Pyoderma gangraenosum

The treatment of pyoderma gangraenosum (PG) is still a therapeutic challenge. Although several drugs such as corticosteroids, dapsone, clofazimine, azathioprine, tacrolimus and cyclosporine A have been shown to be effective in this disease, side-effects of these agents limit their systemic use in seriously ill patients. In recent years, topical treatment of the disease has gained attention. Several reports show an improvement of cutaneous lesions of PG following topical treatment. These earlier reports as well as our own observations suggest that topical therapeutic regimens can be a useful and safe alternative to systemic immunosuppressive therapy in the treatment of PG. We give a review about these topically used drugs and the mechanisms probably involved.

[1]  C. Berking,et al.  Interleukin-8 Overexpression Is Present in Pyoderma Gangrenosum Ulcers and Leads to Ulcer Formation in Human Skin Xenografts , 2000, Laboratory Investigation.

[2]  H. Schuppe,et al.  Topical tacrolimus (FK 506) is effective in the treatment of pyoderma gangrenosum. , 2000, Journal of the American Academy of Dermatology.

[3]  Griffiths,et al.  Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus , 1999, The British journal of dermatology.

[4]  M. Landthaler,et al.  [Therapy-resistant pyoderma gangrenosum--treatment with mycophenolate mofetil and cyclosporine A]. , 1999, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[5]  H. Schuppe,et al.  Topical tacrolimus for pyoderma gangrenosum , 1998, The Lancet.

[6]  V. Ho,et al.  Treatment of pyoderma gangrenosum. , 1996, Journal of the American Academy of Dermatology.

[7]  P. McNair,et al.  Resolution of pyoderma gangrenosum using tacolimus (FK-506) , 1996, Australian and New Zealand journal of medicine.

[8]  S. Brenner,et al.  Topical treatment with 1% sodium cromoglycate in pyoderma gangrenosum. , 1996, Dermatology.

[9]  U. Theissen,et al.  [Successful topical administration of cyclosporin A in pyoderma gangraenosum]. , 1996, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[10]  T. Kanekura,et al.  Successful Treatment of Pyoderma Gangreno‐sum with Nicotine Chewing Gum , 1995, The Journal of dermatology.

[11]  Duffill Mb.  CYCLOSPORINE, AZATHIOPRINE AND LOCAL THERAPY FOR PYODERMA GANGRENOSUM , 1994 .

[12]  M. Duffill.  CYCLOSPORINE, AZATHIOPRINE AND LOCAL THERAPY FOR PYODERMA GANGRENOSUM , 1994, The Australasian journal of dermatology.

[13]  C. Sanders,et al.  Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid. , 1993, Cutis.

[14]  D. Faulds,et al.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. , 1993 .

[15]  R. Yu,et al.  Pyoderma gangrenosum—response to topical nitrogen mustard , 1992, Clinical and experimental dermatology.

[16]  S. Walton,et al.  PYODERMA GANGRENOSUM: ASSOCIATIONS REVISITED , 1992, International journal of dermatology.

[17]  D. V. van Thiel,et al.  Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. , 1991, Transplantation proceedings.

[18]  E. Christophers,et al.  Clearing of Pyoderma gangrenosum by intralesional cyclosporin A , 1991, The British journal of dermatology.

[19]  J. Jorizzo,et al.  Neutrophilic vascular reactions. , 1988, Journal of the American Academy of Dermatology.

[20]  F. Malkinson,et al.  Commentary: Pyoderma Gangrenosum , 1982 .

[21]  Malkinson Fd,et al.  Pyoderma (ecthyma) gangrenosum" by Brunsting, Goeckerman and O'Leary, October 1930. Commentary: Pyoderma gangrenosum. , 1982 .

[22]  M. Thorne,et al.  The treatment of pyoderma gangrenosum with sodium cromoglycate , 1980, The British journal of dermatology.

[23]  P. Lip.  Sodium Cromoglycate (Intal) in the Management of Chronic Leg Ulcers , 1978, Medical Journal of Australia.

[24]  Warin Rp.  Proceedings: Necrobiosis lipoidica diabeticorum disseminata. , 1974 .

[25]  R. Peachey.  Proceedings: Pyoderma gangrenosum of scalp. , 1974, The British journal of dermatology.